specificity for complement receptor function was confirmed by the ability of anti-cr1 antibody to block adherence of lif-treated pmn to eac3b ( 77.0 % inhibition ) and anti-cr3 antibody to block adherence to eac3bi ( 70.2 % inhibition ) .
C0034793
complement
C0079785
cr3